Screener
Aquestive Therapeutics, Inc. AQST Enterprise value
Enterprise value at other companies
Other financials
Where this comes from
Calculated from Aquestive Therapeutics, Inc.’s reported figures.
The source filing: Aquestive Therapeutics, Inc.’s 10-Q, filed May 13, 2026. Open the filing →
- Filed
- May 13, 2026, 4:08 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001398733-26-000030
FAQ
- What is Aquestive Therapeutics, Inc.'s enterprise value?
- Aquestive Therapeutics, Inc. (AQST) reported enterprise value of $460.11M in Q1 2026.
- How has Aquestive Therapeutics, Inc.'s enterprise value changed year-over-year?
- Aquestive Therapeutics, Inc.'s enterprise value increased by 65.5% year-over-year, from $277.97M to $460.11M.
- What is the long-term trend for Aquestive Therapeutics, Inc.'s enterprise value?
- Over 5 years (2020 to 2025), Aquestive Therapeutics, Inc.'s enterprise value has grown at a 31.2% compound annual growth rate (CAGR), from $186.64M to $726.59M.
- What does enterprise value mean?
- Market capitalization plus total debt minus cash, at the quarter end. The cost to acquire the whole business — what an buyer pays for equity and debt, net of the cash they'd inherit.
Ask your AI about Aquestive Therapeutics, Inc.'s enterprise value.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude